| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.02. | Japanese group home operator Amatuhi Holdings triples shares offered ahead of $15 million US IPO | ||
| 06.02. | Hong Kong-based digital marketing firm Feline Culture Holdings files for an $18 million US IPO | ||
| 06.02. | Hong Kong-based IT services firm BAO Holding refiles for a $17 million US IPO | ||
| 06.02. | SPAC Cambridge Acquisition prices $200 million IPO, targeting the technology sector | ||
| 06.02. | SPACSphere Acquisition prices $150 million IPO, offering both warrants and rights | ||
| 06.02. | SPAC SPACSphere Acquisition prices $150 million IPO, led by veterans Bala Padmakumar and Soumen Das | ||
| 06.02. | Chronic eye condition biotech SpyGlass Pharma prices IPO at $16 midpoint, raising $150 million | ||
| 06.02. | Belgian fibrotic disease biotech AgomAb Therapeutics prices IPO at $16 midpoint, raising $200 million | ||
| 06.02. | Jennifer Garner's baby food brand Once Upon a Farm prices IPO at $18 midpoint | ||
| 06.02. | Hong Kong logistics provider Speed Group Holdings increases proposed IPO deal size ahead of $17 million US IPO | ||
| 06.02. | SPAC Kensington Capital Acquisition VI files for a $200 million IPO, targeting the auto industry | ||
| 06.02. | Healthcare-focused holding company Cardiff Lexington revises terms ahead of $6 million Nasdaq uplisting | ||
| 05.02. | SPAC Hennessy Capital VIII prices upsized $210 million IPO, targeting industrial innovation | ||
| 05.02. | SPAC Cantor Equity Partners VI prices $100 million IPO, led by Cantor Fitzgerald | ||
| 05.02. | Electrical equipment maker Forgent Power Solutions prices US IPO at $27 midpoint, raising $1.5 billion | ||
| 05.02. | SPAC Hennessy Capital VIII prices upsized IPO at $10, raising $210 million | ||
| 05.02. | SPAC Cantor Equity Partners VI prices IPO at $10, led by Cantor Fitzgerald | ||
| 05.02. | Electrical equipment maker Forgent Power Solutions prices US IPO at $27, raising $1.5 billion | ||
| 05.02. | Budget furniture retailer Bob's Discount Furniture prices IPO at $17, the low end of the range | ||
| 05.02. | Immuno-responsive cancer biotech Eikon Therapeutics prices upsized IPO at $18 high end | ||
| 05.02. | Asthma-focused AI biotech Generate Biomedicines files for a $100 million US IPO | ||
| 04.02. | Renaissance Capital's January IPO Market Update | ||
| 04.02. | SPAC Apeiron Acquisition files for $70 million IPO, targeting international operations | ||
| 04.02. | Capital markets platform Clear Street Group sets terms for $1.0 billion US IPO | ||
| 04.02. | SPAC Colombier Acquisition III prices $260 million US IPO, led by Omeed Malik |